How Peptides Are Made: Solid-Phase Peptide Synthesis (SPPS) Explained for Non-Chemists

AI generatedhow-toscience
This article was AI-generated for informational purposes only. It is not medical advice. Always verify claims with the cited sources.

Every peptide in a research catalog started as a chain assembled one amino acid at a time. Understanding how that chain is built explains a lot about the numbers you later see on a Certificate of Analysis (COA) — especially the purity percentage. This is a plain-language walkthrough of the dominant manufacturing method, solid-phase peptide synthesis (SPPS). It is educational only, not medical advice.

The core idea: build the chain on a bead

Before 1963, peptides were made in solution, which meant purifying the growing chain after every single step — slow and lossy. Bruce Merrifield's breakthrough was to anchor the peptide to an insoluble plastic bead, called a resin, so the chain stays put while reagents wash over it. Excess reagents and by-products simply rinse away, and the product stays attached to the bead until the very end. That single change made peptide synthesis fast enough to automate, and it earned Merrifield the 1984 Nobel Prize in Chemistry.

A key detail that surprises non-chemists: the chain is built backwards relative to how we write it. Proteins are read from the N-terminus to the C-terminus, but SPPS anchors the C-terminal amino acid to the resin first and adds each new residue onto the free N-terminal end. Assembly runs C-to-N.

Protecting groups: why chemists put caps on amino acids

Amino acids are reactive on more than one end, so left alone they would link up randomly. To force clean, one-at-a-time coupling, chemists use protecting groups — temporary chemical caps that block the parts you don't want reacting yet.

Two strategies dominate, named for the cap on the amino end:

  • Boc (tert-butyloxycarbonyl) — the original approach. Its temporary cap is removed with acid (TFA), and final cleavage historically used hydrogen fluoride (HF), a hazardous reagent.
  • Fmoc (9-fluorenylmethyloxycarbonyl) — now the default. Its temporary cap comes off with a mild base, typically 20% piperidine in DMF, and the whole peptide is later cleaved from the resin with TFA instead of HF. The milder, orthogonal conditions are why Fmoc chemistry dominates most modern synthesis.

    • The repeating cycle: deprotect, couple, wash

    SPPS is one loop run over and over. For each amino acid added:

  • Deprotect. Strip the temporary cap off the N-terminus of the resin-bound chain, exposing a fresh reactive amine.
  • Couple. Activate the carboxyl group of the next protected amino acid with a coupling reagent (such as DIC, HBTU, or PyBOP) and let it form a new peptide bond with that exposed amine.
  • Wash. Rinse away leftover reagents and by-products before the next round.

    • Repeat until the full sequence is assembled. Each residue is one full cycle — a 30-amino-acid peptide means roughly 30 loops.

    Why longer sequences get harder

    Here is the part that connects directly to purity. No coupling step is 100% efficient. If every coupling in a 30-residue synthesis runs at a very good 99%, the theoretical maximum yield of the perfect, full-length chain is only about 74% — because 0.99 multiplied 30 times compounds the small losses. Everything else in the crude mixture is a shorter, wrong chain.

    When a coupling stalls on one bead, that chain simply skips a residue and keeps growing, producing a deletion sequence — a molecule one amino acid short, otherwise nearly identical. Longer chains also tend to fold and clump on the resin (aggregation), which physically blocks reagents and drives even more incomplete couplings. That is why chemists synthesizing sequences beyond ~20 residues often do small test cleavages along the way to check how assembly is going. Longer and "difficult" sequences are inherently harder to make cleanly.

    Cleavage and purification

    When the chain is complete, a TFA cocktail (typically ~95% TFA plus scavengers such as water and triisopropylsilane) cleaves the peptide off the resin and strips the remaining side-chain protecting groups in one step. What you have now is crude peptide — the target molecule mixed with those deletion sequences and other by-products.

    To isolate the correct molecule, the crude is run through preparative reversed-phase HPLC, which separates molecules by tiny differences in how they interact with a column so the right peak can be collected. A separate analytical HPLC run then measures how pure the collected material is — and that percentage is the purity figure reported on a COA.

    Why this matters for a research log

    Purity isn't a marketing adjective; it's the output of this process. A high number means purification successfully pulled the target away from the deletion crowd. That's exactly why we treat the purity tests and COA data as first-class information alongside each entry in the peptide library. Manufacturing quality is one axis; legal and approval status is a completely separate one, which is why we track FDA status on its own. A compound can be synthesized to high purity and still be unapproved for any human use.

    Knowing how a peptide is built makes its paperwork legible: the sequence length hints at synthesis difficulty, and the purity percentage tells you how well the crude was cleaned up.

    PepStash is a research log and reference tool. This article is educational and is not medical advice — it does not diagnose, treat, or recommend any protocol. Regulatory status and trial data change; always verify against primary sources and consult a licensed physician before making any decisions about your health.

    Not medical advice. For research purposes only. Consult a licensed physician before beginning any protocol.